Core E. Biostatistics, Bioinformatics, and Research Design Core
核心 E. 生物统计学、生物信息学和研究设计核心
基本信息
- 批准号:10085153
- 负责人:
- 金额:$ 21.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvanced DevelopmentAffectAnimal ModelAttention deficit hyperactivity disorderBehaviorBehavioral SciencesBioinformaticsBiologyBiometryCaliforniaCellsChromosomesClinicalClinical ResearchClinical TrialsCognitionConsultDataData AnalysesDatabasesDevelopmentDevelopmental Delay DisordersDiGeorge SyndromeDisciplineDiscipline of obstetricsDoctor of PhilosophyDown SyndromeEducationEnsureEpidemiologyFacultyFragile X SyndromeFundingFutureGeneticGenotypeGoalsImmunologyIn VitroIncidenceInstitutesIntegrative TherapyIntellectual and Developmental Disabilities Research CentersKnowledgeMentorsMolecular BiologyMorbidity - disease rateNeurosciencesOutcomePediatric NeurologyPhenotypeProcessPsychiatryPublicationsReproducibilityResearchResearch DesignResearch PersonnelStatistical Data InterpretationStudentsSystemTrainingTranslational ResearchUniversitiesWorkanalytical methodautism spectrum disorderbasebody systemcomplex data designexpectationhigh dimensionalityimprovedinterestmeetingspopulation basedpre-clinicalsenior facultyskillssocial skillstool
项目摘要
PROJECT SUMMARY – BIOSTATISTICS, BIOINFORMATICS, AND RESEARCH DESIGN CORE
The present application seeks funding to continue the MIND Institute Intellectual and Developmental
Disabilities Research Center (IDDRC) at the University of California, Davis. The IDDRC was launched in 2013
and is the newest of the 14 IDDRCs in the network. The Biostatistics, Bioinformatics, and Research Design Core
(BBRDC) is designed to meet the needs of the IDDRC projects and cores at all stages of the research process
by providing access to consulting biostatisticians with a broad range of complementary expertise and a core
manager who will be able to work collaboratively with the biostatisticians and IDDRC investigators to design
studies and provide analytics that ensure that project goals are met and the translational science of IDD is
advanced. The BBRDC will achieve this goal by addressing three specific aims. Aim 1 is to provide statistical
support to MIND Institute IDDRC investigators from a range of disciplines to advance the translational science
of IDD. This support will encompass design, statistical analysis (especially for complex data), and interpretation
of results. Aim 2 is to provide database support for IDDRC investigators, including clinical trials and other
designs, data entry interface, and query-based capabilities. Aim 3 is to provide education and mentoring at all
levels from student to senior faculty in the biostatistical skills and tools necessary for IDD translational research.
The BBRD Core will assist IDDRC investigators and projects in generating high-quality data meeting the
expectations of scientific rigor and reproducibility for publication, while supporting preclinical and clinical
discoveries to advance the translational science of IDD. The Director of the BBRDC is Kyoungmi Kim, PhD.
项目摘要--生物统计学、生物信息学和研究设计核心
本申请寻求资金,以继续智力与发展研究所
加州大学戴维斯分校残疾研究中心(IDDRC)。IDDRC成立于2013年
是该网络14个国际数据中心中最新的一个。生物统计学、生物信息学和研究设计的核心
(BBRDC)旨在满足国际发展研究中心项目和核心在研究进程的所有阶段的需要
通过提供咨询生物统计学家的途径,提供广泛的补充专业知识和核心
能够与生物统计学家和IDDRC调查人员合作设计
研究并提供分析,以确保实现项目目标,并且IDD的翻译科学是
高级。BBRDC将通过实现三个具体目标来实现这一目标。目标1是提供统计数据
对思维研究所IDDRC研究人员的支持,以推动翻译科学的发展
缺铁性贫血患者。这种支持将包括设计、统计分析(特别是复杂数据)和解释
关于结果的。目标2是为IDDRC研究人员提供数据库支持,包括临床试验和其他
设计、数据输入界面和基于查询的功能。目标3是提供教育和指导
从学生到高级教员在生物统计学技能和工具方面的水平,这些技能和工具是IDD翻译研究所必需的。
BBRD核心将协助IDDRC调查人员和项目生成满足以下要求的高质量数据
对出版的科学严谨性和重复性的期望,同时支持临床前和临床
促进IDD翻译科学的发现。BBRDC的主任是金英美博士。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KYOUNGMI KIM其他文献
KYOUNGMI KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KYOUNGMI KIM', 18)}}的其他基金
Core E. Biostatistics, Bioinformatics, and Research Design Core
核心 E. 生物统计学、生物信息学和研究设计核心
- 批准号:
10430111 - 财政年份:2020
- 资助金额:
$ 21.92万 - 项目类别:
Core E. Biostatistics, Bioinformatics, and Research Design Core
核心 E. 生物统计学、生物信息学和研究设计核心
- 批准号:
10682428 - 财政年份:2020
- 资助金额:
$ 21.92万 - 项目类别:
Core E. Biostatistics, Bioinformatics, and Research Design Core
核心 E. 生物统计学、生物信息学和研究设计核心
- 批准号:
10220106 - 财政年份:2020
- 资助金额:
$ 21.92万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 21.92万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 21.92万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 21.92万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 21.92万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 21.92万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 21.92万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 21.92万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 21.92万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 21.92万 - 项目类别: